IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. - Wikidata - wikimedia - TriplyDB

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

http://www.wikidata.org/entity/Q27851676

about

CIViC database Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis.U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysis.Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia Double CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITD.The Frequency and clinical significance of IDH1 mutations in Chinese acute myeloid leukemia patients MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia.Down-regulation of GPX3 is associated with favorable/intermediate karyotypes in de novo acute myeloid leukemia GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia.The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia Redox regulation of the epigenetic landscape in cancer: a role for metabolic reprogramming in remodeling the epigenome Prognostic significance of IDH1 mutations in acute myeloid leukemia: a meta-analysis Reduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemia Pseudogene BMI1P1 expression as a novel predictor for acute myeloid leukemia development and prognosis.GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome Epigenetic dysregulation of NKD2 is a valuable predictor assessing treatment outcome in acute myeloid leukemia.Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.BP1 overexpression is associated with adverse prognosis in de novo acute myeloid leukemia.Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.Association of The IDH1 C.395G>A (R132H) Mutation with Histological Type in Malay Brain Tumors Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia.Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.The prognostic implication of SRSF2 mutations in Chinese patients with acute myeloid leukemia.Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia.Screening for IDH mutations in chronic myelomonocytic leukemia.Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia.IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia.High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia.CD105 (endoglin) is highly overexpressed in a subset of cases of acute myeloid leukemias.Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia.IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes.Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.

P2860

Q27612411-D49BADB0-0922-44B3-BD94-6B1165BCC46D Q27851805-F22CE5F9-C4B6-4522-B51A-DBCFF8AEE0C6 Q27851921-BA387BEE-B829-43C4-898F-637FEDC8C0A6 Q33769072-8EC03760-140F-4F54-B683-D17D07B0E6F1 Q34121336-7DF9A13C-7B60-447F-AD56-A2DC7422F455 Q34502042-94512B79-D675-4BD1-8738-FFABAA28EB9E Q35078037-732BC0E8-FDCF-4BC1-8D01-D8963D0FE61F Q35144877-6F26431B-F5E9-48FE-8824-4D1D2981C8D7 Q35632014-80076702-8110-422C-9070-ABB584BEFB54 Q35835260-85C3EC80-88E4-4F84-BF40-F37D9A6127FA Q35853830-DD3CEA54-44FD-41F9-B41E-34315C5DA2EC Q35854158-FD942BAE-1BD0-40FD-8CC8-020D8DC64E5B Q36428635-AB0AC56D-FB72-41B9-9143-CD0B6DBD7EE4 Q36439908-76E81BB4-7338-4F62-8B08-F67E0EDAB1A9 Q36949308-D63ACAFE-30E0-4CB5-8612-AB8E9E0B96FF Q37565147-BC86AA7A-FDC7-40B7-A467-CF7F49211598 Q37609224-2A4B75E7-8F79-48BE-BDC4-24238F20C895 Q37675993-BC157702-7236-4F0C-9BE8-2ED49C071B3F Q38695398-0769A89A-CC62-4E2D-A9E2-43740F8782E0 Q38716306-2AA00263-5DAD-4FDA-8467-77BF5D5FA0C7 Q38804780-3F75D97B-A347-4C7F-B2A4-E0A5AD4A74B9 Q38819676-4945B00F-8A12-433F-86E2-D4431940FF3A Q38839165-1E5637B1-4E6A-49B0-9025-CC1ECF8DFBBD Q38847748-57491AA5-83C5-4B82-8D33-0EE23DE491CC Q38997694-A2FBB196-9978-41D7-8E3C-1F1AB545497A Q40371904-265DFAFE-F4DC-4FDF-96EC-80D4EF093566 Q40601089-CCD2CB5F-E7FC-420C-B5D1-B3C911E307CF Q40945732-C33E8CC1-6161-42BB-8158-9E006B801941 Q41241298-E30973A3-FCA8-402A-958F-9BA16B8D40DB Q42371609-5049DD4C-3F17-47F4-A9C8-B4DBB1CFF435 Q44179210-6299D6B6-FD10-4AC1-88B6-95945E7305C6 Q44890063-AAC8BD24-F6C9-4231-A088-84BBB2031B84 Q45719667-25A5F907-24F2-4B8C-928C-8E95AD04B9A4 Q46670726-94469819-66A6-4FD2-BCE2-2E75CE98BF12 Q47346339-2E77B6E7-EDF6-4B74-BF3E-1D8194031590 Q47754067-5C40F01C-63DC-43BA-8D92-29814A708595 Q48105461-FB550A41-546F-4340-9BB8-9A3F8D5656CB Q48446071-EE007818-C8D6-447E-8655-28371A886AEE Q48595265-B6921920-0E2F-4868-8C3E-CB2ED9161E87 Q55279230-221905B7-6BFA-45A9-85C5-925B80722CC1

P2860

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

http://www.wikidata.org/entity/Q27851676

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

IDH1 and IDH2 mutation analysi ...... and myelodysplastic syndrome.

@ast

IDH1 and IDH2 mutation analysi ...... and myelodysplastic syndrome.

@en

IDH1 and IDH2 mutation analysi ...... and myelodysplastic syndrome.

@nl

type

label

IDH1 and IDH2 mutation analysi ...... and myelodysplastic syndrome.

@ast

IDH1 and IDH2 mutation analysi ...... and myelodysplastic syndrome.

@en

IDH1 and IDH2 mutation analysi ...... and myelodysplastic syndrome.

@nl

prefLabel

IDH1 and IDH2 mutation analysi ...... and myelodysplastic syndrome.

@ast

IDH1 and IDH2 mutation analysi ...... and myelodysplastic syndrome.

@en

IDH1 and IDH2 mutation analysi ...... and myelodysplastic syndrome.

@nl

P1433

Q27851676-CD2B38B9-0DB9-49C2-9384-4785107AFE96

P1476

Q27851676-C2613CDB-939D-4FC4-B32F-0CAB0C7D4F30

P2093

Q27851676-48FC22AC-43E4-4E87-B52C-6308AC808F1B

Q27851676-6502DC17-7695-482C-9041-0186E4A262C3

Q27851676-7C96453C-D1B9-43D4-BA5B-FEA82DA2AB58

Q27851676-7D2BEEB2-2159-4348-BAF2-99D1E463F0B6

Q27851676-80F6611C-3B21-4FE8-8C5E-9B3253B85A4F

Q27851676-83A0DF38-287D-41CC-85CB-6B06A794CBEC

Q27851676-8B4E568F-A6FF-449D-9A47-D42C2606AD84

Q27851676-AD52873B-A21A-4B3B-992C-6093A2601667

Q27851676-CF610FFD-EF09-46FC-AC74-A6EC1E667BD3

Q27851676-D6009BCC-CD88-47C7-A980-3DCAD02FC245

P2860

Q27851676-0E52A5E8-05F4-4E43-8D50-2D7A6D12A1D4

Q27851676-0EB8ECAC-579F-40B8-9C1E-B15485F7B0E0

Q27851676-0F88D7F6-3BDD-4877-9294-D4D326AB3BA8

Q27851676-28BFBF80-9F54-43B3-ACFA-F676FB5903ED

Q27851676-339036F2-7AC9-474C-A3D2-FFC36752F217

Q27851676-3B897E26-6272-4AB8-BF2F-6E7EC12E3592

Q27851676-3F22CCCE-2BE1-430D-987D-7C5B99E03FB8

Q27851676-442B8A37-AE4B-4E94-8255-8088CC806976

Q27851676-485D1E62-CEF0-4401-B1E4-2EB5CD173C84

Q27851676-4D2BC794-F6F3-4B86-A31B-750B375A0878

P304

Q27851676-37CE175E-D7BB-46E4-9CCD-B520E49CA3F1

P31

Q27851676-AB127F32-AC7F-4A4D-A0B0-66E7625EF32A

P3181

Q27851676-12606313-84B0-482D-8960-74D450C56EF3

P356

Q27851676-18F907CC-3DD7-4418-AFCC-4F07CE9D456A

P433

Q27851676-267F0865-A8FE-480A-842A-26B746D4D0DA

P478

Q27851676-484874F7-46D7-40BE-BAFE-01041B74E06B

P577

Q27851676-A35AA47D-38EC-4FA1-8255-5145B5E5B23E

P698

Q27851676-D36A1596-CB2A-4509-84A6-FD625B5EA37A

P921

Q27851676-9DCB63E5-3797-4F7E-9437-71116F877CB1

P3181

P356

S00277-011-1352-7

P1433

Annals of Hematology

P1476

IDH1 and IDH2 mutation analysi ...... and myelodysplastic syndrome.

@en

P2093

Cui-zhu Wang

http://www.w3.org/2001/XMLSchema#string

Dong-ming Yao

http://www.w3.org/2001/XMLSchema#string

Gao-fei Xiao

http://www.w3.org/2001/XMLSchema#string

Hai-yan Chai

http://www.w3.org/2001/XMLSchema#string

Jiang Lin

http://www.w3.org/2001/XMLSchema#string

Jing Yang

http://www.w3.org/2001/XMLSchema#string

Jun Qian

http://www.w3.org/2001/XMLSchema#string

Qin Chen

http://www.w3.org/2001/XMLSchema#string

Wei Qian

http://www.w3.org/2001/XMLSchema#string

Wen-rong Xu

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

Recurring mutations found by sequencing an acute myeloid leukemia genome

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

P304

519-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4763781

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00277-011-1352-7

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21997850

http://www.w3.org/2001/XMLSchema#string

P921